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Injection of the peptide hormone ghrelin stimulates
food intake in mice and humans. However, mice
born without ghrelin demonstrate no significant
loss of appetite. This paradox suggests either that
compensation develops in mice born without ghrelin
or that ghrelin is not essential for appetite control. To
distinguish these possibilities, we generated trans-
genic mice (Ghrl-DTR) that express the diphtheria
toxin receptor in ghrelin-secreting cells. Injection of
diphtheria toxin in adulthood ablated ghrelin cells
and reduced plasma ghrelin by 80%–95%. Ghrelin
cell-ablated mice exhibited no loss of appetite or
body weight and no resistance to a high-fat diet. To
stimulate food intake in mice by ghrelin injection,
we had to raise plasma levels many-fold above
normal. Like germline ghrelin-deficient mice, the
ghrelin cell-ablated mice developed profound hypo-
glycemia when subjected to prolonged calorie re-
striction, confirming that ghrelin acts to maintain
blood glucose under famine conditions.
INTRODUCTION
Ghrelin is a 28 amino acid peptide hormone secreted by
specialized cells in the stomach (Kojima and Kangawa, 2005).
It requires octanoylation on Ser3 by Ghrelin-O-acyltransferase
(GOAT) (Yang et al., 2008; Gutierrez et al., 2008) in order
to interact with its receptor, the growth hormone secretogogue
receptor (GHSR), which is present in tissues throughout the
body, including the pituitary and hypothalamus (Cruz and Smith,
2008).
The discovery that ghrelin administration stimulates appetite
in rodents (Tscho¨p et al., 2000) and humans (Wren et al., 2001)
led to the hypothesis that ghrelin is an orexigenic antipode
to anorexigenic leptin and raised hopes that pharmacologic
inhibition of ghrelin would prove useful for curbing appetite
and treating obesity (Cummings, 2006; Nass et al., 2011). The
argument that ghrelin functions in vivo as an appetite-
stimulating hormone was bolstered by evidence that its
plasma concentration peaks before meals and falls shortly after
feeding (Cummings et al., 2001; Tscho¨p et al., 2001; Nass54 Cell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc.et al., 2008) and that some forms of bariatric surgery—until
recently, the only FDA-approved treatment for reducing
appetite—suppress ghrelin levels (Cummings et al., 2002),
although the latter observation has been challenged (Saliba
et al., 2009).
Evidence against this ghrelin hypothesis, at least in rodents,
has emerged from studies of ghrelin-deficient mouse models,
none of which have shown a robust reduction in appetite or
body weight (Sun et al., 2003, 2004; Wortley et al., 2004;
Zhao et al., 2010a). Unlike leptin-deficient mice, which are
hyperphagic and morbidly obese (Friedman and Halaas,
1998), ghrelin-deficient mice have normal food intake and
body weight. Similar negative findings were reported for mice
lacking GHSR, the ghrelin receptor (Sun et al., 2004). Indeed,
in mice the major function of ghrelin appears to be in the
control of blood glucose. Ghrelin ablation has been demon-
strated to improve glucose tolerance by increasing insulin
secretion (Sun et al., 2006). Studies performed in our lab-
oratory on Goat/ mice revealed an essential function for
ghrelin in maintaining blood glucose during periods of chronic
starvation (Zhao et al., 2010a; Goldstein et al., 2011; Li et al.,
2012).
The negative results with germline ghrelin knockouts might
be explained if the mice develop compensation owing to the
lifelong ghrelin deficiency. A precedent exists in the work of
Luquet et al. (2005), who showed that ablation of AgRP/NPY
neurons in the arcuate hypothalamus causes a loss of appetite
when performed in adult, but not neonatal, mice. AgRP/NPY
neurons express the GHSR and are thought to be critical for
the appetite-stimulating effect of ghrelin (Cowley et al., 2003).
The conditional ablation of ghrelin in an adult animal is therefore
necessary to understand the influence of ghrelin levels on appe-
tite in vivo.
In the current studies, we ask whether inhibition of
ghrelin signaling in an adult mouse affects food intake or
body weight. We generated transgenic mice that express
the diphtheria toxin receptor (DTR) specifically on ghrelin-
secreting cells (designated Ghrl-DTR mice). When injected
with diphtheria toxin (DTX) in adulthood, Ghrl-DTR mice lost
their ghrelin cells within 24 hr and experienced a decline in
plasma ghrelin levels of 80%–95%. Ghrelin levels were
maintained below 80% of normal for at least 4 weeks and
could be maintained at lower levels with repeated administra-
tions of DTX. We found no change in food intake or body
weight in the setting of ghrelin cell ablation in the short or
long term.
Figure 1. Plasma Hormones and Stomach mRNAs of Control and
Ghrl-DTR Mice over 9 Days following Injection of DTX
(A–F) Chow-fed control and Ghrl-DTR littermates (8-week-old males) were
injected intraperitoneally with 8–10 ng/g body weight of DTX at the indicated
time prior to sacrifice. To obtain groups of n = 6, two identical n = 3 studies
were performed on consecutive days and combined into one data set.
Injections of DTX were staggered such that the indicated time points were
reached at 2 p.m. (the circadian maximum of ghrelin concentration) on the day
of sacrifice. Uninjected controls are shown at time 0. After anesthetization by
isoflurane, blood was drawn from the inferior vena cava, after which the whole
stomach was divided in half longitudinally and immediately homogenized in
RNA STAT-60 (Tel-Test, Inc.). Plasma measurements for ghrelin (A), des-acyl
ghrelin (B), and insulin (C) were determined by ELISA as described in the
Experimental Procedures. mRNA levels for ghrelin (D), chromogranin A (E),
and TNF-a (F) were measured by quantitative RT-PCR on stomach RNA and
normalized to cyclophilin mRNA. Each value represents mean ± SEM of 6
mice, except the Ghrl-DTR groups at 8 hr and 3 days, which represent n = 5
and n = 4 mice, respectively. One mouse at the 8 hr time point and two mice at
the 3-day time point did not respond to DTX as indicated by PCR of stomach
RNA; the values for these mice were omitted from the data. **p < 0.01; ***p <
0.001.
Cell Metabolism
Induced Ablation of Ghrelin Cells in Adult MiceRESULTS
Administration of DTX to Ghrl-DTR Mice Destroys
Ghrelin-Secreting Cells and Reduces Circulating
Ghrelin
Employing the recombination strategy described in the Experi-
mental Procedures and schematized in Figure S1 (available
online), we generated transgenic mice that express the simian
DTR selectively in ghrelin-producing cells (Ghrl-DTR mice).
When the mice reached 8 weeks of age, we administered a
single dose of DTX intraperitoneally (8–10 ng/g body weight) to
Ghrl-DTR mice and to control littermates. Groups of 6 micewere killed at 8, 24, 72, and 216 hr after DTX injection. The
12 hr light cycle began at 9 a.m., and all mice were killed within
30 min of 2 p.m., which corresponds to the peak of the circadian
cycle of plasma ghrelin in control mice (Figure S2). Plasma was
obtained for hormone measurements, and stomach tissue was
harvested for mRNA measurements. In Ghrl-DTR mice, the
DTX injection produced a 50% reduction in plasma ghrelin within
8 hr. By 24 hr, the level had declined to 14% of normal, and it
remained at this low level through 9 days (Figure 1A). The decline
in des-acyl ghrelin was equally rapid, but not quite as profound,
the level averaging 20%of normal through the 9 days (Figure 1B).
Plasma insulin levels were unaffected by the DTX injection in
either control or Ghrl-DTR mice (Figure 1C).
The level of ghrelin mRNA in stomach extracts declined in
parallel with the fall in plasma ghrelin levels (Figure 1D). The
mRNA encoding chromogranin A, a protein found in all gastric
endocrine cells, fell by 29% in the Ghrl-DTR mice (Figure 1E).
This is consistent with the estimate that ghrelin cells account
for 20% of chromogranin A-containing cells in the stomach
(Date et al., 2000). We saw no significant increase in the mRNA
encoding tumor necrosis factor alpha (TNF-a) in the stomach
extracts, which suggests that DTX did not elicit an inflammatory
response in the stomach (Figure 1F).
To examine the architecture of the stomach, we prepared
histological sections of stomachs of control and Ghrl-DTR
mice that were killed 9 days after DTX injection. The animals
were part of the group studied in Figure 1. Figures 2A and 2D
show that stomach architecture was preserved in Ghrl-DTR
mice after DTX injection. In control mice, we easily detected cells
that stained positive for ghrelin (Figure 2B). We saw no such cells
in the stomachs from the Ghrl-DTR mice (Figure 2E). Abundant
chromogranin A-positive cells were observed in control and
Ghrl-DTR stomachs (Figures 2C and 2F). We did not observe
any histological signs of inflammation in these stomachs, nor
did we detect anymorphological changes or alterations in insulin
or glucagon staining in pancreatic islets.
Acute Ablation of Ghrelin Cells Does Not Alter Food
Intake or Body Weight
To measure daily food intake and body weight, we housed mice
in individual cages for 2 weeks (starting on day 7). DTX was
injected on day 0. Ghrelin and des-acyl ghrelin levels were
measured on day 7 and day 0 before injection and on days 2
and 7 after injection (Figures 3A–3C). On average, plasma ghrelin
fell by 80% and des-acyl ghrelin levels fell by 76% in Ghrl-DTR
mice relative to littermate controls. Despite these reductions in
the 7 days following injection of DTX, we observed no alteration
in food intake, which averaged 3.6 ± 0.1 g/day in both groups
(Figure 3D), or body weight, which averaged 21.2 ± 0.3 g in
both groups (Figure 3E). No differences in blood glucose levels
were observed (Figure 3F).
Ghrelin Deficiency Does Not Prevent Diet-Induced
Obesity
We subjected groups of 11–14 control or Ghrl-DTRmice to either
a chow diet or a high-fat diet (HFD) for 12 weeks. Mice were
housed in cages of four that contained mixed genotypes. Inves-
tigators were blinded to genotype for all sample collections and
assays. DTX was injected in all mice during week 1, and repeatCell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc. 55
Figure 2. Stomach Histology of Control and
Ghrl-DTRMice 9 Days after Injection of DTX
(A–F) Stomachs were harvested 9 days after
injection of DTX from the same control (A–C) and
Ghrl-DTR (D–F) mice shown in Figure 1. Repre-
sentative sections of the gastric fundus are shown.
Serial sections were stained as follows: (A and D)
hematoxylin and eosin, (B and E) anti-ghrelin
antisera, (C and F) anti-chromogranin A antisera.
Magnification, 103; scale bar, 250 mm.
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and Ghrl-DTR mice gained equal amounts of weight on the
high-fat diet (Figure 4A), and they exhibited equal increases in
body fat (Figure 4B). Plasma measurements of insulin, ghrelin,
des-acyl ghrelin, and total ghrelin were made biweekly at 2
p.m. in all mice (Figures 4C–4F). Area under the curve calcula-
tions beginning after injection of DTX and extending until the
end of the study indicate an average reduction in plasma ghrelin
of 85% and 89% in chow- and HFD-fed Ghrl-DTR mice relative
to chow-fed control mice (Figure 4D). Corresponding reductions
in des-acyl ghrelin were 79% and 87%, respectively (Figure 4E).
In control mice, the HFD reduced plasma ghrelin by 38% and
des-acyl ghrelin by 49% (Figures 4D and 4E). The significance
of this finding is unknown but consistent with observations in
humans showing that plasma ghrelin levels are significantly
lower in obese subjects than in lean subjects (Shiiya et al.,
2002). In the HFD-fed groups, hyperinsulinemia (>3 ng/ml) devel-
oped in control and Ghrl-DTR mice between weeks 6 and 9 of
high-fat feeding (Figure 4C).
Ghrelin Cells Are Necessary to Prevent Profound
Hypoglycemia during Calorie Restriction
Weshowedpreviously thatmicegenetically deficient for acylated
ghrelin (Goat/) become severely hypoglycemic during 60%
calorie restriction (Zhao et al., 2010a; Goldstein et al., 2011; Li
et al., 2012). The same was true of genetic ghrelin deficiency (Li
et al., 2012). To determine whether ablation of ghrelin cells in
adulthood would reproduce this result, we subjected control
and Ghrl-DTR mice (n = 8) to 7 days of 60% calorie restriction.
These animals were fed each day at 6 p.m. Blood glucose
was measured at 5:30 p.m., just before feeding (Figure 5). Inas-
much as calorie-restricted wild-type and ghrelin-deficient mice
consume all of their food within 1 hr (Zhao et al., 2010a), the
mice in Figure 5 have been fasting for 23.5 hr when the blood is
collected at 5:30 p.m. Beginning on day 4 and continuing through
day 7 of calorie restriction, we observed a decline in blood sugar
in Ghrl-DTR mice relative to control mice, with Ghrl-DTR mice
reaching a nadir of 24 ± 4 mg/dl on day 7, while control mice
averaged 72 ± 5 mg/dl (Figure 5B). These results are similar to
those observed in calorie-restricted wild-type and Goat/
mice (Zhao et al., 2010a), confirming that the presence of ghrelin
during calorie restriction is necessary to protect against fasting-
induced hypoglycemia. By day 7 of calorie restriction, ghrelin
levels in control mice reached 2.2 ± 0.21 ng/ml, while levels in56 Cell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc.Ghrl-DTR mice were undetectable (i.e.,
<0.07 ng/ml) (Figure 5D). Des-acyl ghrelin
levels reached 5.7 ± 0.62 ng/ml in controlanimals and were 0.12 ng/ml in Ghrl-DTR mice, a reduction of
98% (Figure 5C).
Ghrelin Administration Stimulates Food Intake Only at
Supraphysiologic Doses in Control and Ghrl-DTR Mice
The failure of ghrelin cell ablation to reduce food intake in mice
contrasts with many previous experiments that have demon-
strated that injections of ghrelin cause an acute increase in
food consumption (Tscho¨p et al., 2000; Wren et al., 2001; Kojima
and Kangawa, 2005). In an attempt to reconcile these findings,
we injected doses of ghrelin ranging from 0.01 to 1 mg/kg to
control and Ghrl-DTR mice (Figure 6). At 4 days after injection
of DTX, we injected the mice subcutaneously with ghrelin or
saline solution and measured food intake over the following
2 hr. The experiment was initiated at 2:00 p.m. (5 hr after begin-
ning of the light cycle), a time in which mice normally consume
only small amounts of food. Injection of 0.01 mg/kg ghrelin failed
to increase food intake in control and Ghrl-DTRmice (Figure 6A).
At a 10-fold higher dose of ghrelin (0.1 mg/kg), there was a
marked increase in food intake over the first 30 min in both
control and Ghrl-DTR mice, after which there was little further
increase. Another 10-fold dose increase (1 mg/kg) produced a
slightly higher food intake at 30 min, and the mice continued to
eat an increased amount over 2 hr. Again, the response of control
and Ghrl-DTR mice was indistinguishable.
We could not measure plasma ghrelin levels during the food
intake experiments because it would have disrupted the feeding
pattern of the mice. To obtain plasma for ghrelin determination,
we repeated the saline or ghrelin injections on the next day at
the same time and measured the plasma level of ghrelin and
des-acyl ghrelin after 10 min. Plasma ghrelin was reduced by
97% in the saline-injected Ghrl-DTR mice as compared with
controls. Injection of ghrelin at 0.01 mg/kg raised the plasma
ghrelin level in the Ghrl-DTR mice so that it equaled the level in
the control mice, yet there was no increase in food intake (Fig-
ures 6A and 6B). A dose of 0.1 mg/kg, which increased food
intake, raised the plasma ghrelin level to 453 the value in
saline-injected control mice. At 1 mg/kg, ghrelin injection raised
the plasma ghrelin level to 650-fold above the saline-injected
level (from 0.53 to 345 ng/ml) (Figure 6B, top). The values for
des-acyl ghrelin paralleled those for ghrelin (Figure 6B, bottom).
We measured plasma growth hormone (GH) in the same sam-
ples and found that a ghrelin dose of 0.1 mg/kg was required
to raise GH in control mice (Figure S4).
Figure 4. Body Weight of Control and Ghrl-DTR Mice during High-
Fat Feeding
(A–F) Control and Ghrl-DTR littermates (8-week-old males) were housed in
cages containing four mice of mixed genotype. Mice were fed either a chow
diet or a HFD for 12 weeks as indicated andwere injected intraperitoneally with
DTX at the indicated time. Body weight (A) was measured weekly. Body fat (B)
was measured monthly. Blood was drawn biweekly at 2:00 p.m. Plasma levels
of insulin (C), ghrelin (D), and des-acyl ghrelin (E) weremeasured by ELISA, and
values in (D) and (E) were added together to give values for total ghrelin (F).
Dotted lines denote times of DTX injection. Each value representsmean ± SEM
of 11–15 mice. One control mouse was incorrectly genotyped, and three Ghrl-
DTR mice in the chow-fed group did not respond to DTX; the values for these
mice were omitted from the data. HFD, high-fat diet.
Figure 3. Body Weight and Food Intake of Control and Ghrl-DTR
Mice before and after Ablation of Ghrelin Cells
(A–F) Chow-fed control and Ghrl-DTR littermates (8-week-old males) were
housed individually and injected intraperitoneally with DTX on day 0. Blood
was drawn by tail vein at 2:00 p.m. on the indicated day. Ghrelin (A) and des-
acyl ghrelin (B) levels were measured by ELISA and added together to give
total ghrelin (C). Food intake (D) and body weight (E) were measured daily at 2
p.m. Experimenters were blinded to the genotypes of the mice for body weight
and food intake measurements. Blood glucose (F) was measured by Bayer
Glucometer. Dotted lines denote time of DTX injection. Each value represents
mean ± SEM of eight or nine mice. One mouse that did not respond to DTX (by
ghrelin and des-acyl ghrelin measurements) was excluded.
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order to increase food intake acutely, plasma ghrelin must be
elevated above physiological levels. To explore this phenome-
non over a narrower concentration range, we repeated the ghre-
lin injections in control mice and measured food intake over the
next 30 min (Figure 6C). On the next day, we repeated the injec-
tions and measured plasma ghrelin 10 min later. Injection of
0.025 mg/kg of ghrelin raised the plasma level of ghrelin 143
the level in saline-injected mice, but it did not increase food
intake significantly. When the dose was raised to 0.05 mg/kg,
plasma ghrelin increased 80-fold, and food intake increased
by 7.2-fold. A similar 8-fold increase in food intake was
observed when the ghrelin dose was further increased to
0.1 mg/kg. Thus, in this experiment, as in the experiment of
Figures 6A and 6B, it was necessary to raise plasma ghrelin
many-fold above normal in order to observe an acute increase
in food intake.
DISCUSSION
The rationale for the current experiments is based on the exper-
imental design of Luquet et al. (2005), who used diphtheria toxin
(DTX) to ablate NPY/AgRP neurons that were engineered toexpress the human DTX receptor. When the neurons were
ablated in neonatal mice, there was little reduction in food intake,
but ablation in adult mice induced starvation. These findings
could be explained if compensatory changes ameliorated the
effect of ablation when performed in young animals, obscuring
the true role of NPY/AgRP neurons. We reasoned that a similar
type of life-long compensation might be obscuring the anorexic
effects of ghrelin deficiency when the gene for ghrelin, GOAT, or
the ghrelin receptor is disrupted in the germline. Therefore, we
engineered ghrelin-secreting cells to produce the simian DTX
receptor and ablated those cells by injecting DTX in adult
mice. The result was identical to the one that we obtained earlier
in studies of ghrelin and GOAT germline knockout mice (Zhao
et al., 2010a; Li et al., 2012). The ghrelin cell-ablated mice
showed no reduction in food intake, and they gained weight as
rapidly as controls when placed on a high-fat diet. This study
therefore rules out neonatal compensation as an explanation
for the failure of ghrelin deficiency to alter food intake in mice.
It should be noted that the current studies were designed spe-
cifically to test the effect of acute ghrelin ablation on overall food
intake. We did not address the previously reported effects ofCell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc. 57
Figure 5. Comparison of Control and Ghrl-DTR Mice Subjected to
60% Calorie Restriction
(A–D) Chow-fed control and Ghrl-DTR littermates (8-week-old males) were
housed individually and injected intraperitoneally with DTX on day 0.Micewere
subjected to 60% calorie restriction for 7 days as described in the Experi-
mental Procedures. Body weight (A) was measured daily at 5:30 p.m. Blood
was drawn from the tail vein at 5:30 p.m. every day for glucose measurement
(B) and every 2–3 days for measurement of plasma levels of des-acyl ghrelin
(C) and ghrelin (D) by ELISA. Each value represents mean ± SEM of eight mice.
**p < 0.01; ***p < 0.001.
Figure 6. Food Intake of Control and Ghrl-DTRMice Following Ghre-
lin Injection
(A and B) Chow-fed control and Ghrl-DTR littermates (8-12 weeks old male)
were housed individually and injected with DTX on day 0. On day 2, plasma
ghrelin and des-acyl ghrelin weremeasured to verify ablation in Ghrl-DTRmice
(Figure S3), andmicewere randomly sorted into eight groups of fivemice each.
On day 4 at 2:00 p.m., mice of both genotypes were injected subcutaneously
with 0.1 ml of 0.15 MNaCl containing the indicated amount of ghrelin. (A) Food
intake was measured at 0, 0.5, 1, and 2 hr after injection. (B) On the following
day, identical injections of ghrelin were given, and blood was drawn from the
tail vein 10 min after injection of the indicated concentration of ghrelin. Levels
of ghrelin (top) and des-acyl ghrelin (bottom) were measured by ELISA.
(C) Chow-fed control and Ghrl-DTR littermates (not injected with DTX) were
randomized into five groups of mixed genotype (n = 6). On the first day of the
experiment, mice were injected subcutaneously at 2:00 p.m. with the indicated
dose of ghrelin (top), and food intake (bottom) wasmeasured at 10 and 30min,
respectively, after injection as described in (A). On the following day, identical
injections of ghrelin were given, and blood was drawn from the tail vein 10 min
later, as described in (B). Each value represents mean ± SEM of five mice
(A and B) or six mice (C). **p < 0.01; ***p < 0.001.
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food-reward behavior and depression (Lutter et al., 2008;
Chuang et al., 2011).
Although deprivation of ghrelin did not reduce food intake in
the Ghrl-DTR mice, the injection of excess ghrelin increased
food intake in Ghrl-DTRmice aswell as in control mice. An expla-
nation for this paradox emerged when we measured the ghrelin
level 10 min after the injections (Figures 6A and 6B). In both ex-
periments, ghrelin stimulated food intake only when the plasma
level was raised above the normal concentration. The highest
ghrelin concentration that we have observed in the diurnal
rhythm of normal mice is 0.5–0.6 ng/ml (Figures S2 and 6B).
Even after a 24 hr fast, plasma ghrelin rises to only 0.9 ng/ml.
Yet, when we injected 0.025 mg/kg ghrelin into control mice,
we raised the plasma level to 2.7 ng/ml (14-fold above normal)
without a significant increase in food intake. When we doubled
the ghrelin dose to 0.05 mg/kg, plasma ghrelin rose by 80-fold
to 16 ng/ml and food intake was significantly increased. The
feeding response to supraphysiologic ghrelin levels is known to
require the ghrelin receptor (Sun et al., 2004), thus indicating
that the receptor is far from saturated, even at the highest ghrelin
levels that are observed in normal or fasting conditions.
The requirement for supraphysiologic ghrelin levels to stimu-
late appetite and raise GH appears to explain the normal food
intake of mice lacking ghrelin or the ghrelin receptor from birth
(Sun et al., 2003, 2004; Wortley et al., 2004; Zhao et al., 2010a).
Humansmay also require supraphysiologic ghrelin levels to stim-
ulate appetite, as shown by Lippl et al. (2012), who infused ghre-
lin to normal-weight volunteers and found no increase in appetite
even when plasma ghrelin was raised 4-fold above control58 Cell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc.values. These researchers cited nine previous studies in which
increased food intake in humans was observed at doses of ghre-
lin that raised plasma ghrelin levels many-fold above normal.
Thus far, the only documented essential requirement for ghre-
lin is to maintain life-preserving levels of blood glucose when
mice have been depleted of adipose tissue through prolonged
severe calorie restriction. In this respect, the ghrelin cell-ablated
mice behaved identically to mice that lack GOAT or ghrelin from
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2011). In control mice, ghrelin levels rise progressively during this
period, and GH levels follow. Administration of ghrelin or GH
prevents the hypoglycemia, indicating that the essential role of
ghrelin is prevention of hypoglycemia during periods of extreme
food deprivation (Zhao et al., 2010a; Goldstein et al., 2011).
In a paper published in PLOS ONE, Yi et al. (2012) recently
reported that, in contrast to our findings, they did not observe
selective profound hypoglycemia in germline GOAT knockout
mice during prolonged calorie restriction. In our lab, we have
observed selective profound hypoglycemia in calorie-restricted
GOAT and ghrelin knockout mice in more than 100 experiments
conducted over the past five years. As pointed out in the Exper-
imental Procedures, demonstration of profound hypoglycemia
requires careful attention to the experimental protocol. Among
a number of differences from our protocol, the mice studied by
Yi et al. (2012) were not housed in individual cages, had a higher
starting fat mass, and were fed a diet higher in carbohydrates. All
of these differences would require restandardization of the pro-
tocol as well as a longer period of calorie restriction in order to
observe selective profound hypoglycemia.
EXPERIMENTAL PROCEDURES
Generation of Mice with DTX-Inducible Ablation of Ghrelin-
Producing Cells
All mice (C57BL/6J background unless otherwise indicated) were housed in
cages with 12 hr light/12 hr dark cycles. The dark cycle began at 9:00 or
10:00 p.m. All animal experiments were performed with approval of the Insti-
tutional Animal Care and Research Advisory Committee at the University of
Texas Southwestern Medical Center.
To generate Ghrl-DTRmice (Figure S1), we crossed Ghrelin-Cre mice (gift of
Jeffrey L. Zigman, UT Southwestern) (Engelstoft et al., 2013) to inducible
diphtheria toxin receptor (iDTR) mice (Jackson Laboratory; #007900). The
Ghrelin-Cremice, when crossed to a reporter strain, activated reporter expres-
sion predominantly in the stomach (>96% of ghrelin cells), but not in the
pancreas or brain (Engelstoft et al., 2013). The iDTR strain contains a modified
Rosa26 locus in which a flox-inactivated copy of the simian Hbegf gene
(commonly known as diphtheria toxin receptor gene; DTR) has been inserted
(Buch et al., 2005). Expression of Cre recombinase removes a premature stop
codon and activates transcription of DTR, conferring DTX sensitivity to ghrelin
cells. Mice with the genotypeGhrl-Cre; iDTRf/f orGhrl-Cre; iDTRf/+ were desig-
nated Ghrl-DTR, and littermates without the ghrelin-cre transgene (iDTRf/+ or
iDTRf/f) were used as control mice.
For all experiments, DTX (Sigma; catalog number D0564) was dissolved in
normal saline at a concentration of 1.0–1.2 mg/ml, and an injection of 200 ml
was administered intraperitoneally to all mice, including controls. This corre-
sponds to a dose of 8–10 ng DTX/g body weight. Of all mice used in these
studies, 91% experienced a robust ablation of ghrelin cells after a single
DTX injection; 9% showed no response to DTX administration. Partial
responses were not observed in any of the injected mice.
Diets
The chow diet (Teklad Mouse/Rat Diet 7002; Harlan Teklad Global Diets)
contains 3.0 kcal/g of metabolizable energy, of which 18% of calories are
from fat, 49% from carbohydrates, and 33% from protein. For high-fat diet
(HFD) studies, mice were fed a diet containing 45% calories from fat. The
diet was composed of 24 g% fat, 41 g% carbohydrate, and 24 g% protein
(Research Diets; catalog number D12451). Total body fat was measured by
NMR (Bruker minispec mq7.5 NMR analyzer).
Calorie Restriction
Calorie restriction for studies of ghrelin-mediated control of blood glucose was
carried out as previously described (Zhao et al., 2010a; Li et al., 2012). Essen-tial requirements for reproducibility include the following: (1) baseline food
intake must be measured separately for each mouse so that the calories can
be reduced by 60% for each individual mouse (this requires that the mice be
housed in individual cages; our rooms are maintained at 22C); (2) ghrelin-defi-
cient mice will not become hypoglycemic until their total body fat is reduced
below 2% of body weight, after which they are fasted for 23 hr; and (3) it is
essential not to stress the mice in any way because stress lowers blood
glucose in the calorie-restricted wild-type mice.
In the current studies, 8-week-old male control and Ghrl-DTR littermates
were placed in individual cages for 1 week before initiation of calorie restriction
and then fed the chow diet ad libitum. During this week, food intake was
monitored to determine the average daily food consumption of each individual
mouse. On day 0, all mice received a single intraperitoneal (i.p.) injection of
8–10 ng/g DTX and were subjected to 60% calorie restriction such that each
mouse was fed 40% of its average food consumption daily at 6:00 p.m.
Body weight and blood glucose were measured daily at 5:30 p.m. before
feeding.
Administration of Ghrelin
Mice were briefly anesthetized with isoflurane and injected subcutaneously
with0.1 ml of 0.15 M sodium chloride containing the indicated concentration
of ghrelin (GenScript, catalog number RP10781-5).
Blood Collection and Hormone Measurements
For measurements in which mice were kept alive (Figures 3, 4, 5, 6, S2, and
S3), 10–30 ml of tail vein blood was collected. For measurements in which
mice were sacrificed (Figures 1, S1, and S4), mice were anesthetized with
isoflurane, after which 500–700 ml of blood was drawn from the inferior vena
cava (Figures 1 and S1) or the orbit (Figure S4). Blood samples were stored
in EDTA-coated tubes containing p-hydroxymercuribenzoic acid (final con-
centration, 1 mM). Plasma was separated into two aliquots and stored at
80C: one for insulin or GH measurements and the other for ghrelin/
des-acyl ghrelin measurements, the latter stored in HCl (final concentration,
0.1 M). Ghrelin and des-acyl ghrelin were measured with immunoassay kits
from Cayman Chemical that distinguish both forms of the peptide (catalog
numbers 10006307 and 10008953). Insulin was measured with an ELISA kit
from Crystal Chem (catalog number 90080). GH was measured with an ELISA
kit from Cayman Chemical (catalog number 589601).
Quantitative Real-Time PCR
Total RNAwas isolated frommouse kidney, liver, duodenum, and whole stom-
ach, after which the mRNAs were subjected to real-time PCR using primers for
mouse cyclophilin, ghrelin, and chromogranin A as previously described (Zhao
et al., 2010b). Additional primers used (forward and reverse) were as follows:
mouse TNF-a, 50-CTGAGGTCAATCTGCCCAAGTAC-30 and 50-CTTCACA
GAGCAATGACTCCAAAG-30; cre recombinase, 50-GGCCCAAATGTTGCTG
GAT-30 and 50-TGTTCGCGATTATCTTCTATATCTTCA-30; simian HBEGF, 50-
AGGCAAGGGACTAGGGAAGA-30 and 50-CCACCACAGCCAGGATAGTT-30.
All reactions were done in triplicate. The relative amount of all mRNAs was
calculated using the comparative threshold cycle (Ct) method. Cyclophilin
mRNA was used as the invariant control.
Histology
Stomachs were fixed for 20–48 hr in 4% (v/v) paraformaldehyde in PBS. The
fixed tissues were embedded in paraffin and sectioned at 4 mm. For immuno-
histochemistry, slides were pretreated with 0.3% (v/v) hydrogen peroxide for
15 min at room temperature, followed by antigen retrieval for 10 min at 98C
in Retrievagen A buffer (BD Biosciences). The slides were then incubated
for 1 hr at room temperature in 10% (v/v) normal goat serum (NGS; Vector
Laboratories) in PBS, followed by overnight incubation at 4C with anti-ghrelin
antiserum (1:1,000 dilution in 10% NGS; Phoenix Pharmaceuticals, code
H-031-31, lot number 01241-3) or anti-chromogranin A antiserum (1:400 in
10% NGS; Abcam, code ab15160, lot number GR121602-3). Slides were
then incubated for 1 hr at room temperature with anti-rabbit antiserum (1:500
in 10% NGS; Jackson ImmunoResearch), followed by 60 min at room temper-
ature in Streptavidin-HRP conjugate (1:750 in 10% NGS; Invitrogen). Activity
was developed for 1min with an AECSubstrate Kit (Invitrogen), counterstained
with hematoxylin, and mounted using Aqua-Poly/Mount (Polysciences).Cell Metabolism 20, 54–60, July 1, 2014 ª2014 Elsevier Inc. 59
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